TOLINASE Drug Patent Profile
✉ Email this page to a colleague
When do Tolinase patents expire, and what generic alternatives are available?
Tolinase is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in TOLINASE is tolazamide. There are six drug master file entries for this compound. Additional details are available on the tolazamide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TOLINASE?
- What are the global sales for TOLINASE?
- What is Average Wholesale Price for TOLINASE?
Summary for TOLINASE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 1 |
| Patent Applications: | 5,891 |
| DailyMed Link: | TOLINASE at DailyMed |
Recent Clinical Trials for TOLINASE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Novartis | Phase 2 |
US Patents and Regulatory Information for TOLINASE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | TOLINASE | tolazamide | TABLET;ORAL | 015500-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmacia And Upjohn | TOLINASE | tolazamide | TABLET;ORAL | 015500-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmacia And Upjohn | TOLINASE | tolazamide | TABLET;ORAL | 015500-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
